CyGenica

CyGenica is an Irish biopharmaceutical company that develops GEENIE technology to deliver therapeutic molecules directly into cell interiors from headquarters in Ireland.

Here are key aspects of the company:

• Products & Services: The company offers a groundbreaking engineered protein nanoneedle called GEENIE, which features a unique cell entry mechanism designed to bypass endosomes for precise and efficient intracellular delivery.
• Industries: CyGenica operates within the biopharmaceutical sector, specifically focusing on advanced therapies aimed at treating cancers and rare disorders that currently lack effective treatments due to high toxicity or side effects limiting therapeutic potential.
• Innovation: By ensuring 100% of therapeutic molecules reach their intracellular target without being hindered by endosomal barriers, the GEENIE technology redefines what is possible in drug delivery systems ranging from nucleotides to proteins.

CyGenica seeks visionary biopharmaceutical partners to collaborate on transforming intracellular drug delivery and unlocking new possibilities for advanced therapies through its unique nanoneedle platform.